Bionanotechnology News

RSS

Nanoparticle Vaccine Therapy for Type 1 Diabetes

Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-fun...

9 Apr 2010

World’s Largest Particle Accelerator Achieves Highest Energy Collisions

The Large Hadron Collider is the world’s largest and highest-energy particle accelerator — a 17-mile loop under the Franco-Swiss border that was built by the European Organization for Nuclear Research (CERN) to help scientists answer some of the most fundamental questions in physics.

8 Apr 2010

Newly Developed Molecular Gauge Helps to Study Workings of DNA

Luminescent markers are an indispensable tool for researchers working with DNA. But the markers are troublesome. Some tend to destroy the function and structure of DNA when inserted. Others emit so little light, tha...

7 Apr 2010

USPTO Issues pRNAi Nanotechnology Patent to Kylin Therapeutics

Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office (USPTO).

7 Apr 2010

ICG-Labeling with Iron Oxide-Based Nanoparticles Helps to Study Dynamics of Stem Cells

A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs)...

7 Apr 2010

Scientists Recorded Almost 200,000 Films Revealing Human Genes Involved in a Range of Functions

EU-funded scientists have recorded almost 200,000 films that reveal the human genes involved in a range of functions including one of the most fundamental processes of life: cell division. Details of their groundbreaking...

6 Apr 2010

FNA Cell Block Samples Now Analyzed Using Rosetta’s MicroRNA-Based Diagnostic Tests

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics’ CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta’s miRview squamous test.

6 Apr 2010

Bionanotechnology News

Nanoparticle Vaccine Therapy for Type 1 Diabetes

World’s Largest Particle Accelerator Achieves Highest Energy Collisions

Newly Developed Molecular Gauge Helps to Study Workings of DNA

USPTO Issues pRNAi Nanotechnology Patent to Kylin Therapeutics

ICG-Labeling with Iron Oxide-Based Nanoparticles Helps to Study Dynamics of Stem Cells

Scientists Recorded Almost 200,000 Films Revealing Human Genes Involved in a Range of Functions

FNA Cell Block Samples Now Analyzed Using Rosetta’s MicroRNA-Based Diagnostic Tests

Development of New Tissue and Bone Scaffolding Polymer Using Nanoparticle Core

Development of A New Method in Fluorescence Microscopy

Company To Advance New Class of Synthetic Vaccines into Clinical Development Based on tSVP Platform

Automated Image Acquisition and Analysis of Graphene and Hexagonal Boron Nitride Structures

Breakthrough in Broadband Photodetectors: Nanomaterial Gii Could Bring Faster Broadband and Higher Quality Medical Imaging

A New Understanding of Metal-Carbon Interactions

Enhancing Solid-State Lithium Batteries with Nano-Ceramic Electrolytes

A New Language for Nanopore Design

Conversations on AFM: Applications of BioAFM in Life Science

Conversations on AFM: The Technology and History Behind AFM and SPM

Recent Advances in High-Speed Atomic Force Microscopy to Improve Research Into Protein Dynamics

Sponsored Content

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials

What are Mesoporous Silica Nanoparticles?

Carbon-Based Nanomaterials: Overcoming Challenges in Air Sensitivity for Next-Generation Batteries